Oxygenta [OXYGENTAPH] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Oxygenta

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Oxygenta wins in 12 metrics, Suven Life Sciences wins in 6 metrics, with 0 ties. Oxygenta appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricOxygentaSuven Life SciencesBetter
P/E Ratio (TTM)444.32-28.31Suven Life Sciences
Price-to-Book Ratio-10.3141.36Oxygenta
Debt-to-Equity Ratio-2.490.00Oxygenta
PEG Ratio1.38-0.34Suven Life Sciences
EV/EBITDA-24.19-24.12Oxygenta
Profit Margin (TTM)-13.45%84.44%Suven Life Sciences
Operating Margin (TTM)-50.72%-2,791.92%Oxygenta
Return on Equity38.69%-146.15%Oxygenta
Return on Assets (TTM)-11.61%-118.91%Oxygenta
Free Cash Flow (TTM)$-87.89M$-1.91BOxygenta
1-Year Return-20.28%49.21%Suven Life Sciences
Price-to-Sales Ratio (TTM)2.22632.35Oxygenta
Enterprise Value$3.17B$44.90BSuven Life Sciences
EV/Revenue Ratio2.84597.31Oxygenta
Gross Profit Margin (TTM)-24.33%100.00%Suven Life Sciences
Revenue per Share (TTM)$31$0Oxygenta
Earnings per Share (Diluted)$-3.95$-8.45Oxygenta
Beta (Stock Volatility)0.420.78Oxygenta
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Oxygenta vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Oxygenta
Suven Life Sciences
Oxygenta Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Oxygenta1.06%1.69%-4.31%-39.94%-9.48%-18.70%
Suven Life Sciences0.37%3.79%-10.27%-21.82%76.25%63.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Oxygenta-20.28%144.99%530.20%969.02%609.78%191.63%
Suven Life Sciences49.21%215.69%329.98%-26.12%600.33%3,806.72%

News Based Sentiment: Oxygenta vs Suven Life Sciences

Oxygenta

News based Sentiment: NEGATIVE

September brought concerning financial results for Oxygenta Pharmaceutical, with a substantial increase in net loss and a declining share price. While the AGM took place, the underlying financial challenges and mixed investor signals create a negative outlook for the month, making it a significant period for investors to reassess their positions.

View Oxygenta News Sentiment Analysis

Suven Life Sciences

News based Sentiment: MIXED

October was a month of conflicting signals for Suven Life Sciences. While the company benefited from a positive pharmaceutical sector rally and maintained a debt-free status, it also reported continued quarterly losses and received a negative analyst rating. This creates a complex investment narrative with both potential opportunities and significant risks.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Oxygenta vs Suven Life Sciences

MetricOXYGENTAPHSUVEN
Market Information
Market Cap i₹2.61B₹47.99B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i6,823184,111
90 Day Avg. Volume i7,182150,383
Last Close₹69.70₹209.40
52 Week Range₹67.00 - ₹133.50₹102.50 - ₹299.99
% from 52W High-47.79%-30.20%
All-Time High₹133.50 (Jun 09, 2025)₹338.50 (Apr 13, 2015)
% from All-Time High-47.79%-38.14%
Growth Metrics
Quarterly Revenue Growth0.20%0.86%
Quarterly Earnings GrowthN/A0.86%
Financial Health
Profit Margin (TTM) i-0.13%0.84%
Operating Margin (TTM) i-0.51%-27.92%
Return on Equity (TTM) i0.39%-1.46%
Debt to Equity (MRQ) i-2.490.00
Cash & Liquidity
Book Value per Share (MRQ)₹-7.15₹5.04
Cash per Share (MRQ)₹0.03₹2.75
Operating Cash Flow (TTM) i₹-61,057,000₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹-96,826,000₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Oxygenta vs Suven Life Sciences

MetricOXYGENTAPHSUVEN
Price Ratios
P/E Ratio (TTM) i444.32-28.31
Forward P/E iN/A10.78
PEG Ratio i1.38-0.34
Price to Sales (TTM) i2.22632.35
Price to Book (MRQ) i-10.3141.36
Market Capitalization
Market Capitalization i₹2.61B₹47.99B
Enterprise Value i₹3.17B₹44.90B
Enterprise Value Metrics
Enterprise to Revenue i2.84597.31
Enterprise to EBITDA i-24.19-24.12
Risk & Other Metrics
Beta i0.420.78
Book Value per Share (MRQ) i₹-7.15₹5.04

Financial Statements Comparison: Oxygenta vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)OXYGENTAPHSUVEN
Revenue/Sales i₹151.35M₹18.67M
Cost of Goods Sold i₹188.17M₹0
Gross Profit i₹-36.83M₹18.67M
Research & Development iN/A₹414.88M
Operating Income (EBIT) i₹-76.77M₹-521.17M
EBITDA i₹-66.61M₹-501.49M
Pre-Tax Income i₹-81.48M₹-515.17M
Income Tax i₹-20.42M₹0
Net Income (Profit) i₹-61.06M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)OXYGENTAPHSUVEN
Cash & Equivalents i₹17,000₹150.26M
Total Current Assets i₹309.43M₹754.72M
Total Current Liabilities i₹858.47M₹234.86M
Long-Term Debt i₹215.22MN/A
Total Shareholders Equity i₹-250.25M₹1.10B
Retained Earnings i₹-735.63M₹-6.01B
Property, Plant & Equipment i₹14.36M₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)OXYGENTAPHSUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOXYGENTAPHSUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i6,823184,111
Average Daily Volume (90 Day) i7,182150,383
Shares Outstanding i36.98M218.07M
Float Shares i3.88M67.61M
% Held by Insiders i0.80%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Oxygenta vs Suven Life Sciences

MetricOXYGENTAPHSUVEN
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A